Clinical Trial Update: A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy [Phase 2]

View source ↗

Summary

This Phase 2 study from Memorial Sloan Kettering Cancer Center evaluated a myeloablative conditioning regimen with total body irradiation followed by transplant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cancer, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-02-12